Global Cannabinoid Solutions (GCS) today announced the launch of its Bespoke Clinical Curriculum service, an extension of its clinical training suite for medical cannabis prescribers, doctors and pharmacists.

Practitioners understand cannabinoids in theory. They struggle to connect that knowledge to a specific patient's condition in a way that demonstrates expertise. They know HOW cannabinoids work. They're uncertain how to explain WHY this cannabinoid helps THIS patient.

At its core, GreenShield is designed to raise the safety floor for everyone, regardless of professional title or prior experience. It is GCS’s way of giving back—offered completely free as part of our public health mission.

Investors often unknowingly back ventures that lack scientific governance. Clinicians operate without ECS education. Operators are left second-guessing product safety, patient communication, and regulatory language. These gaps aren’t just inefficient—they're dangerous, costly, and often exist below the surface until it’s too late.

For many organisations, the challenge is no longer whether cannabinoid science matters, but how to engage with it in a way that is structured, credible, and proportionate.

Access to high-quality science has traditionally required significant institutional investment. Laboratories, research teams, academic partnerships, and long development timelines have formed the backbone of scientific capability.

New products, new claims, and new market entrants have appeared at a pace that has often exceeded the capacity of underlying scientific understanding to keep up.

Seed Our Future receives the 2025 GreenShield Award for a decade of advocacy, community support and responsible leadership led by Guy and Hellen Coxall across the UK.

Intractable receives the 2025 GreenShield Award for their leadership in advocacy, public support and sector wide progress for families affected by intractable epilepsy.

Dalgety is recognised with the 2025 GreenShield Award for leading UK cannabis education, uniting sector organisations and expanding public understanding of cannabinoid medicine.

The Cannabis Trades Association is honoured with the 2025 GreenShield Award for a decade of leadership, advocacy and industry support across the UK cannabis sector.

Over the past year, Lyphe Clinic has undertaken one of the most ambitious internal education initiatives of any medical cannabis provider in the UK. At a time when the sector still struggles with fragmented knowledge, inconsistent training, and a lack of shared scientific frameworks, Lyphe took a decisive step: They became one of the first clinics in the country to implement a unified, standardised cannabis literacy framework across their entire team.